Drugs / Pearlium/EffectiCal
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04609189 | Jul 2012 → May 2014 | postmenopausal osteoporosis | University of Alberta | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pearlium/Effecti-Cal | “Pearlium®/Effecti-Cal®, a Novel Formulation of Calcium, Vitamin D and Minerals for Prevention of Postmenopausal Bone Loss” NCT04609189 ↗ |
| Route | Oral | “Oral administration of Pearlium/EffectiCal.” NCT04609189 ↗ |